XenoPort: Xenoport Inc. Files SEC Form SC 14D9/A, Solicitation, Recommendation Statements (Jun. 24, 2016)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Xenoport Inc. (Form SC 14D9/A) was posted on Jun